OCULAR MYASTHENIA GRAVIS

Clinical trials for OCULAR MYASTHENIA GRAVIS explained in plain language.

Never miss a new study

Get alerted when new OCULAR MYASTHENIA GRAVIS trials appear

Sign up with your email to follow new studies for OCULAR MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1

New drug shows promise for rare eye muscle disease in Long-Term trial

Disease control Not yet recruiting

This study looks at the long-term safety and effectiveness of a drug called rozanolixizumab for adults with ocular myasthenia gravis, a condition that causes muscle weakness in the eyes. About 100 people who have already taken the drug in a previous study will continue treatment.…

Matched conditions: OCULAR MYASTHENIA GRAVIS

Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control

Last updated Jun 27, 2026 11:01 UTC

OCULAR MYASTHENIA GRAVIS

Get alerted when new OCULAR MYASTHENIA GRAVIS trials appear

New drug shows promise for rare eye muscle disease in Long-Term trial